Browsing: Immunovia AB

LUND, Sweden, Nov. 9, 2023 /PRNewswire/ — July-September 2023 Net sales amounted to KSEK 488 (358) divided by sales of…

LUND, Sweden, July 12, 2023 /PRNewswire/ — Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic…

LUND, Sweden, June 9, 2023 /PRNewswire/ — Immunovia AB (Nasdaq: IMMNOV) announces today that Jeff Borcherding, CEO of Immunovia, has…

LUND, Sweden, May 31, 2023 /PRNewswire/ — The number of shares and votes in Immunovia AB (publ) (“Immunovia”) have changed as…

LUND, Sweden, May 26, 2023 /PRNewswire/ — On 26th May 2023, an Annual General Meeting (AGM) was held in Immunovia AB…

LUND, Sweden, May 6, 2023 /PRNewswire/ — Philipp von Hugo, member of the board of directors of Immunovia AB (publ)…

LUND, Sweden, April 20, 2023 /PRNewswire/ — Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world’s first test…

LUND, Sweden, Feb. 23, 2023 /PRNewswire/ —  October-December 2022            Net sales amount kSEK 502 (305) divided by sales of tests…

LUND, Sweden, Feb. 20, 2023 /PRNewswire/ — Immunovia AB (publ), reg. no. 556730-4299, hereby gives notice that an Extraordinary General…